According to industry reports, injectable biologics are one of the fastest growing segments of the biopharmaceutical market today.  Significant revenues are now being generated by blockbuster biologics, and with other injectable biologics coming to market in new therapeutic areas, a greater emphasis is being placed on combination products that will help patients to take these medications.

The majority of these biologics, including follow on biologics or biobetters, biosimilars and even generic injectables, will generally require more effective delivery systems.  This has led to a corresponding surge in the demand for various injection devices. An example of such devices is the pen injector, which allows the patient to safely self-administer the drug in the comfort of their own home. SHL offers a diverse range of pen injector products designed to meet customer’s specifications while meeting end-user needs at the same time.